Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the company would contemplate new talks with insurers regarding the listing prices of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Elevance lowers assistance on https://lorenzorizof.boyblogguide.com/29965445/not-known-factual-statements-about-healthcare-news